UPLC | GenomeWeb

UPLC

Georgia Tech researchers used high-performance mass spectrometry to uncover a highly accurate 16-marker signature that identifies women with ovarian cancer.

NEW YORK (GenomeWeb News) – Waters today reported that its revenues in the first quarter were up 2 percent year over year, driven by a resurgence in instrument sales, particularly mass spectrometers.

NEW YORK (GenomeWeb News) – Waters is offering its Acquity UPLC System with online solid phase extraction technology from Spark Holland under a deal announced today between the firms.

NEW YORK (GenomeWeb News) – Waters and the UK's The Food and Environment Research Agency today announced they are establishing a laboratory-based training facility to improve food safety detection.

The companies will co-market mass spectrometry tools with characterization software.

According to President and CEO Douglas Berthiaume, LC and mass spec instrument sales both grew at rates of over 20 percent as the company saw "continued rapid uptake" of its Acuity H-Class UPLC and Xevo mass spectrometry systems.

New 2010 releases like Waters' Xevo TQ-S triple quadrupole machine and AB Sciex's TripleTOF 5600 helped spur strong revenue growth, said company officials during Q4 earning calls this week.

With executives from Agilent, Thermo Fisher, Waters, and Danaher presenting this week at the JP Morgan Healthcare Conference, UPLC as well as triple quadrupole and qual-quan mass spec proved primary areas of discussion.

The release of a long-awaited protein biomarker test, increased adoption of a major instrument platform, and a pair of proteome mapping milestones marked a year in which several much-anticipated advances in proteomics arrived.

Pages

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.